ABT vs BSX
Abbott Laboratories (ABT) and Boston Scientific (BSX) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $66.2B for Boston Scientific, about 2.7 times the size. On trailing earnings, BSX is cheaper at 18.5x versus 38.6x for ABT.
Head to head
| Metric | ABT | BSX |
|---|---|---|
| Market cap | $179.4B | $66.2B |
| P/E (TTM) | 38.6x | 18.5x |
| Forward P/E | 17.4x | 13.5x |
| Revenue (TTM) | $48.2B | $21.0B |
| Revenue growth | 14.5% | 7.5% |
| Gross margin | 57.1% | 69.2% |
| Operating margin | 11.3% | 22.9% |
| Free cash flow | $7.4B | $1.8B |
| Dividend yield | 2.43% | None |
| 1-year return | -15.9% | -55.4% |
| 5-year return (annual) | -2.0% | +0.4% |
| Max drawdown | -46% | -89% |
| FI Handbook grade | C+ | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs BSX FAQ
Which is bigger, ABT or BSX?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $66.2B for Boston Scientific, about 2.7 times the size.
Is ABT or BSX cheaper?
On trailing earnings, BSX is cheaper at 18.5x versus 38.6x for ABT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or BSX?
ABT returned -15.9% over the past year including dividends, versus -55.4% for BSX, through October 23, 2026.
Which pays a higher dividend, ABT or BSX?
ABT yields 2.43%; BSX does not pay a dividend.
Full pages: Abbott Laboratories · Boston Scientific